10. THE CHECK IS IN THE MAIL: A NOVEL APPROACH TO CHLAMYDIA TRACHOMATIS TESTING USING SELF COLLECTED, MAILED SPECIMEN

Abstract

Background: The progress in chlamydia testing/management seems to have stalled in Australia over the last years with persistent high prevalences observed in known risk groups. A novel approach is needed to lower the barriers to testing especially in those who are socially isolated and/or live in rural or remote locations.

Aim: To develop, implement and evaluate a novel approach to chlamydia testing in the form of a 'self-collection testing kit' that is easily accessible, confidential, free of charge, easy to use, and allows for home self-collection of specimens, their transportation by regular mail and the central management (notification, treatment and follow-up) of results.

Methods: The developed 'kit' consists of all necessary items and instructions to obtain a sample. A network of 'kit' distribution sites at locations frequented by the target population has been established in urban as well as rural and remote areas. The 'kits' can also be requested via an advertised website and a 1800 phone number. Specimens are returned via reply paid mail. A centralised system for the management of results and follow up of individuals has been developed. Test results are conveyed to participants by the method of their choice including email, SMS and phone. Treatment is organised via a network of health care providers in various locations.

Results/Discussion: First promising results and experiences from the implementation phase of this novel approach to chlamydia testing will be presented covering distribution and uptake of 'kits', return of specimens as well as management and follow up.

If eventually proven successful, this approach to chlamydia testing will provide significant opportunities for increasing access to testing across Australia especially in rural and remote areas. An extension to gonorrhoea testing is possible.

This project is supported by the 'National Chlamydia Pilot Program' funding of innovative chlamydia projects.